story of the week
No Survival Benefit With IV Immunoglobulin for Toxic Epidermal Necrolysis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Role of Intravenous Immunoglobulins in Toxic Epidermal Necrolysis: A Retrospective Analysis of 64 Patients Managed in a Specialized Centre
Br J Dermatol 2013 Dec 01;169(6)1304-1309, HY Lee, YL Lim, T Thirumoorthy, SM PangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.